Navigation Links
Pharm-Olam Finds VoIP Solution in Taridium LLC
Date:5/7/2008

NEW YORK, May 7 /PRNewswire/ -- When leading contract research organization Pharm-Olam International (POI, http://www.pharm-olam.com) upgraded its legacy PBX system to a voice-over Internet protocol (VoIP) system that would better serve the company's global communications needs, the results were nothing short of catastrophic.

POI initially selected a local vendor to plan, develop and deploy a VoIP system, but it was immediately clear the solution was a bigger problem than the old PBX.

"It was a total disaster. The system crashed virtually every day, voice quality was terrible, remote staff had connectivity issues, and the vendor had spend over six months trying to bring the system live in the UK office," stated R. Michael Shassere, POI global director of IT. "I knew I had to find a fix quickly. I also did not want to lose the recent investment in the Polycom desk sets we had just purchased."

So Shassere set about finding a company that could both implement a better VoIP system and correct the problems the local vendor had created. POI executives agreed VoIP -- done right -- was the perfect solution to their needs. The technology was proven, so the obvious issue was the original vendor. Shassere researched larger vendors like Fonality and Switchbox, along with some other local providers.

"I was not impressed, especially with the deployment plans that required significant time from POI IT staff, or with the after-sale support options," Shassere explained. "I had almost lost hope of finding the right vendor when I contacted Taridium. After just a few minutes on the phone, I knew this was the vendor I needed."

POI initially contracted with premier VoIP solutions provider Taridium LLC (http://www.taridium.com) to resolve the system issues in the company's UK office. Taridium brought the system up and operational in just a few short days -- something the previous vendor had failed to do in several months.

"We were elated. Taridium has now installed its system in several of our worldwide sites so far, and we will have them do all the sites as time permits," said Shassere. "We could not be happier."

About Pharm-Olam International

Based in Houston, Texas, POI is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. The company has experienced significant growth in the past few years and now has offices located in 22 countries around the globe. More information is available at http://www.pharm-olam.com.

About Taridium LLC

Taridium is the leader in open standards enterprise and provider VoIP solutions. The company's offering ranges from managed VoIP services for small and medium-sized businesses to high-capacity telephony solutions for large enterprises and service providers. Taridium's products and services are designed to harness the power of open standards while reducing both ownership and telecommunication expenses. To learn more, visit http://www.taridium.com.

Contact:

R. Michael Shassere

Pharm-Olam International

713-559-7995

michael.shassere@pharm-olam.com

http://www.pharm-olam.com

Astra Baxley

Taridium LLC

212-461-1600

astra.baxley@taridium.com

http://www.taridium.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Taridium LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Phase III Trial Finds Pharmaxis Bronchitol Effective
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. HU scientist finds way to catch terrorists red-handed
4. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
5. Unique infrared technique finds applications in nanoscience
6. Study Finds Broadband Access Key to Empowerment of Minority Communities
7. Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood
8. Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
11. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... three months ended December 31, 2016. SQI ... diagnostics company that develops and commercializes proprietary technologies and products ... ... commercial milestones achieved in fiscal 2016," said Andrew Morris ...
(Date:2/21/2017)... ... ... The medical potential of stem cells is both extensive and astounding, and ... their differentiating characteristics. Stem cells are unique as the have the potential to renew ... tissue or organic-specific cells with special functions. , Stem cell therapy in the ...
(Date:2/21/2017)... 21, 2017  Lexus, a returning partner of the Amgen ... and exclusive automobile partner of the men,s and women,s events for ... The 2017 Amgen Tour of California will ... of the best professional cycling teams in the world racing from ... four-day Amgen Breakaway from Heart Disease TM Women,s ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... to announce that it has been approved for full, active membership in the ... Dallas, Texas, was founded by Chief Executive Officer Jeff Olson in ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):